Andrew Ng

Hong Kong, Hong Kong
Andrew Ng is a Managing Director and Head of Healthcare of VMS Group and an Investment Partner of Panacea Venture. He has over 13 years of experience in the healthcare industry across Asia and the US. Andrew established the healthcare practice of VMS Group in 2017 and led multiple growth-stage investments for VMS across the therapeutics, diagnostics, medical device and CRO/CDMO verticals.
Prior to that, Andrew was responsible for the China Healthcare Equity Research at Barclays Capital based in Hong Kong. Before that, he was an investment banker covering healthcare clients across the Asia Pacific region at Barclays Capital, with a focus in healthcare cross-border M&A. Andrew started his career as a management consultant at ZS Associate in the United States, advising global pharma on sales & marketing strategy and operations.
Andrew received an MBA from INSEAD, and a M.Eng. degree and a B.S. degree in Operations Research & Engineering from Cornell University.
Speaking In
1:00 PM - 2:00 PM (PDT)
Monday, June 13
Innovation and patients have brought us all closer than ever before despite an uncertain…